Skip to content
Acorai logo — The new standard in heart failure management

Acorai

The new standard in heart failure management

Founded 2019 Sweden Sweden 25 employees Non Equity Assistance Total: $47.75M Health Care, Medical Devices +1

General Information

Company Name Acorai
Founded Year 2019
Location Sweden Sweden
Employees 25
Industries Health Care, Medical Devices, Pharmaceutical
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Acorai. To contact Acorai, visit acorai.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Acorai compare?

A PDF of Acorai and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Acorai soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Acorai

Acorai is a progressive startup revolutionizing heart failure management with its innovative non-invasive intracardiac pressure monitoring (ICPM) device. The company's slogan "The new standard in heart failure management" captures its commitment to improving patient outcomes. By leveraging machine learning analysis of pressure dynamics in acoustics, vibratory, and waveform data, Acorai's product demonstrates remarkable precision, presenting a promising solution to reduce hospitalizations and readmissions. The startup's last investment of $4.50M in a Seed Round at 19 January 2024, led by CerraCap Ventures, KHP Ventures, Solardis Health Ventures, and Carma Fund, attests to the confidence of prominent investors in the company's potential. Acorai's technology showcases a low-risk clinical and regulatory pathway, minimal dependence on reimbursement, and a rapid route to commercialization, signaling a bright future for the company in the Health Care and Pharmaceutical sectors. Headquartered in Sweden, Acorai embodies the cutting-edge advancements in the healthcare industry.

With its pioneering approach to heart failure management, Acorai possesses the potential to significantly impact patient care and healthcare systems, making it an appealing prospect for venture capital investment. The company's strategic focus on non-invasive monitoring aligns with the growing demand for technologies that improve patient outcomes while lowering healthcare costs. Additionally, Acorai's strong financial backing from reputable investors underscores its credibility and potential for growth, making it a compelling opportunity for venture capitalists seeking promising ventures in the healthcare sector.

Business keywords: MedTech, Cardiology, Heart Failure Management, Non-invasive Monitoring, Medical Device, FDA Breakthrough Device, Clinical Validation, Regulatory Pathway, Commercialization, Intracardiac Pressure Monitoring, Digital Health, Cardiovascular, Clinical Advisors

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
MedTech Innovator
29 May 2024
Seed Round $4.50M 5
CerraCap Ventures, KHP Ventures +3
19 Jan 2024
Grant €2.30M 1
European Innovation Council
08 Nov 2023
Seed Round kr10.95M 3
Golden Angels Investors, Springboard Health Angels +1
01 Mar 2023
Non Equity Assistance Undisclosed 4
The Cedars-Sinai Accelerator, Mayo Clinic +2
24 Nov 2022
Seed Round kr14.46M 2
KHP Ventures, HealthTech Arkansas
01 Apr 2022
Pre Seed Round kr10.06M 1
Bayer G4A
15 Jun 2021
Grant kr5.48M -
25 May 2021

Acorai Alternatives & Competitors

View All Alternatives
Acorai vs

Harness the power of respiratory-based treatment for hypertension and heart failure with innovative...

Post-IPO Equity
Biotechnology, Health Care
Acorai vs
Impulse Dynamics
Impulse Dynamics United States

A cardiac medical device company determined to improve the lives of heart failure patients through C...

Venture round
239 employees
Biotechnology, Health Care
Acorai vs

Presenting the ModulHeart. Low-risk heart support for patients with advanced heart failure

Series A
32 employees
Health Care, Medical Devices

FAQ About Acorai

The new standard in heart failure management
Acorai was founded in 2019.
Acorai is headquartered in Sweden.
Acorai operates in Health Care, Medical Devices and Pharmaceutical. Its work centres on MedTech, Cardiology, Heart Failure Management and Non-invasive Monitoring.
Acorai has approximately 25 employees.
Acorai has completed 8 funding rounds, raising a total of $47.75M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Acorai include InterCure, Impulse Dynamics, Puzzle Medical Devices Inc., BioVentrix, Reprieve Cardiovascular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acorai and InterCure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Acorai, https://bouncewatch.com/company/acorai, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout